Primary |
Drug Use For Unknown Indication |
23.0% |
Cardiac Disorder |
17.9% |
Angina Pectoris |
13.5% |
Hypertension |
10.4% |
Chest Pain |
7.8% |
Product Used For Unknown Indication |
4.4% |
Cardiovascular Disorder |
3.8% |
Coronary Artery Disease |
2.2% |
Heart Rate Irregular |
1.8% |
Myocardial Infarction |
1.8% |
Blood Pressure |
1.6% |
Myocardial Ischaemia |
1.6% |
Cardiac Failure Congestive |
1.5% |
Suicide Attempt |
1.5% |
Anxiety |
1.3% |
Pain |
1.3% |
Prinzmetal Angina |
1.3% |
Type 2 Diabetes Mellitus |
1.3% |
Depression |
1.1% |
Acute Coronary Syndrome |
0.9% |
|
Product Quality Issue |
49.9% |
Syncope |
10.2% |
Cardiovascular Disorder |
8.9% |
Vomiting |
4.0% |
Renal Failure |
2.5% |
Renal Failure Acute |
2.5% |
Death |
2.2% |
Myocardial Infarction |
2.2% |
Unresponsive To Stimuli |
2.0% |
Weight Decreased |
2.0% |
Ventricular Tachycardia |
1.7% |
Headache |
1.5% |
Vertigo |
1.5% |
Vision Blurred |
1.5% |
Drug Ineffective |
1.2% |
Hypotension |
1.2% |
Palpitations |
1.2% |
Stent Placement |
1.2% |
Tachycardia |
1.2% |
Tremor |
1.2% |
|
Secondary |
Product Used For Unknown Indication |
37.6% |
Drug Use For Unknown Indication |
8.8% |
Hypertension |
8.2% |
Type 2 Diabetes Mellitus |
5.0% |
Diabetes Mellitus |
4.7% |
Angina Pectoris |
4.2% |
Cardiac Disorder |
3.6% |
Cardiovascular Disorder |
3.1% |
Convulsion |
3.0% |
Chest Pain |
2.9% |
Cardiac Failure Chronic |
2.7% |
Coronary Artery Disease |
2.7% |
Crohn's Disease |
2.6% |
Multiple Drug Overdose |
2.4% |
Blood Cholesterol Increased |
1.5% |
Gastrooesophageal Reflux Disease |
1.5% |
Insomnia |
1.5% |
Depression |
1.3% |
Migraine |
1.3% |
Pain |
1.3% |
|
Colitis Microscopic |
9.8% |
Hypotension |
9.8% |
Abnormal Dreams |
8.7% |
Angioedema |
6.0% |
Loss Of Consciousness |
6.0% |
Emphysema |
5.5% |
Shock |
5.5% |
Nausea |
4.9% |
Renal Failure |
4.9% |
Vomiting |
4.9% |
Renal Failure Acute |
4.4% |
Mental Disorder |
3.8% |
Product Quality Issue |
3.8% |
Syncope |
3.8% |
Amnesia |
3.3% |
Orthostatic Hypotension |
3.3% |
Suicide Attempt |
3.3% |
Intestinal Obstruction |
2.7% |
Pemphigoid |
2.7% |
Ventricular Arrhythmia |
2.7% |
|
Concomitant |
Product Used For Unknown Indication |
36.6% |
Drug Use For Unknown Indication |
23.7% |
Hypertension |
8.0% |
Angina Pectoris |
4.5% |
Cardiac Disorder |
2.8% |
Diabetes Mellitus |
2.8% |
Prophylaxis |
2.5% |
Coronary Artery Disease |
2.4% |
Rheumatoid Arthritis |
2.0% |
Pain |
1.8% |
Atrial Fibrillation |
1.8% |
Myocardial Ischaemia |
1.5% |
Cardiac Failure |
1.5% |
Depression |
1.5% |
Myocardial Infarction |
1.2% |
Type 2 Diabetes Mellitus |
1.2% |
Blood Cholesterol Increased |
1.2% |
Hypercholesterolaemia |
1.2% |
Asthma |
0.9% |
Chronic Obstructive Pulmonary Disease |
0.9% |
|
Vomiting |
10.6% |
Rhabdomyolysis |
10.5% |
Myocardial Infarction |
9.3% |
Weight Increased |
6.7% |
Weight Decreased |
5.4% |
Death |
5.3% |
Renal Failure Acute |
5.2% |
Pneumonia |
4.8% |
Urinary Tract Infection |
4.5% |
Syncope |
3.9% |
Renal Failure |
3.8% |
Renal Impairment |
3.6% |
Sepsis |
3.6% |
Angina Pectoris |
3.5% |
White Blood Cell Count Increased |
3.4% |
International Normalised Ratio Increased |
3.2% |
Thrombocytopenia |
3.2% |
Drug Interaction |
3.2% |
Nausea |
3.2% |
Dyspnoea |
3.1% |
|
Interacting |
Overdose |
41.2% |
Angina Pectoris |
9.3% |
Product Used For Unknown Indication |
8.2% |
Prophylaxis |
6.2% |
Ventricular Arrhythmia |
6.2% |
Acute Coronary Syndrome |
4.1% |
Hypertension |
4.1% |
Hypertensive Nephropathy |
4.1% |
Abdominal Symptom |
2.1% |
Atrial Fibrillation |
2.1% |
Dyslipidaemia |
2.1% |
Vaginal Haemorrhage |
2.1% |
Agitation |
1.0% |
Blood Cholesterol |
1.0% |
Blood Cholesterol Increased |
1.0% |
Cardiovascular Event Prophylaxis |
1.0% |
Chest Pain |
1.0% |
Dyspepsia |
1.0% |
Erectile Dysfunction |
1.0% |
Off Label Use |
1.0% |
|
Renal Failure |
33.3% |
Drug Interaction |
14.3% |
Ventricular Arrhythmia |
14.3% |
Diarrhoea |
9.5% |
Malaise |
9.5% |
Gout |
4.8% |
Hepatitis Cholestatic |
4.8% |
Rhabdomyolysis |
4.8% |
Vertigo |
4.8% |
|